Global Digital Biomarkers Market 2023-2029
The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global digital biomarkers market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors approaches.
This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the type, system components, application, end user, and region. The global market for digital biomarkers can be segmented by type: clinical trials, clinical settings. Among these, the clinical settings segment was accounted for the highest revenue generator in 2022. Digital biomarkers market is further segmented by system components: wearables, mobile apps, implantables, data integration software. The wearables segment is estimated to account for the largest share of the global digital biomarkers market. Based on application, the digital biomarkers market is segmented into: gastrointestinal diseases, sleep and movement disorders, cardiovascular, psychiatric disorders (mood and behavior), chronic pain, neurodegenerative diseases, diabetes, respiratory diseases, others. The cardiovascular segment held the largest share of the global digital biomarkers market in 2022 and is anticipated to hold its share during the forecast period. On the basis of end user, the digital biomarkers market also can be divided into: biopharmaceutical companies, payers, providers. In 2022, the biopharmaceutical companies segment made up the largest share of revenue generated by the digital biomarkers market. Digital biomarkers market by region is categorized into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America.
Market Segmentation
By type: clinical trials, clinical settings
By system components: wearables, mobile apps, implantables, data integration software
By application: gastrointestinal diseases, sleep and movement disorders, cardiovascular, psychiatric disorders (mood and behavior), chronic pain, neurodegenerative diseases, diabetes, respiratory diseases, others
By end user: biopharmaceutical companies, payers, providers
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
The report has also analysed the competitive landscape of the global digital biomarkers market with some of the key players being Alphabet Inc., AliveCor Inc., Akili Interactive Labs, Inc., Dassault Systmes SE, IXICO plc, Koninklijke Philips N.V., Quanterix Corp., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
Scope of the Report
To analyze and forecast the market size of the global digital biomarkers market.
To classify and forecast the global digital biomarkers market based on type, system components, application, end user, region.
To identify drivers and challenges for the global digital biomarkers market.
To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global digital biomarkers market.
To identify and analyze the profile of leading players operating in the global digital biomarkers market.
Why Choose This Report
Gain a reliable outlook of the global digital biomarkers market forecasts from 2023 to 2029 across scenarios.
Identify growth segments for investment.
Stay ahead of competitors through company profiles and market data.
The market estimate for ease of analysis across scenarios in Excel format.
Strategy consulting and research support for three months.
Print authentication provided for the single-user license.
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
PART 5. MARKET BREAKDOWN BY TYPE
Clinical trials
Clinical settings
PART 6. MARKET BREAKDOWN BY SYSTEM COMPONENTS
Wearables
Mobile apps
Implantables
Data integration software
PART 7. MARKET BREAKDOWN BY APPLICATION
Gastrointestinal diseases
Sleep and movement disorders
Cardiovascular
Psychiatric disorders (mood and behavior)
Chronic pain
Neurodegenerative diseases
Diabetes
Respiratory diseases
Others
PART 8. MARKET BREAKDOWN BY END USER
Biopharmaceutical companies
Payers
Providers
PART 9. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 10. KEY COMPANIES
Alphabet Inc.
AliveCor Inc.
Akili Interactive Labs, Inc.
Dassault Systmes SE
IXICO plc
Koninklijke Philips N.V.
Quanterix Corp.
DISCLAIMER
Global Whole Exome Sequencing Market 2023
DescriptionThe Whole Exome Sequencing Market is poised for substantial growth, with a projected increase from USD 1.43 billion in 2022 to USD 3.75 billion by 2029. This growth is expected
USD 1950 View ReportGlobal Continuous Bioprocessing Market 2023
DescriptionThe global Continuous Bioprocessing Market size is anticipated to expand from USD 133.9 million in 2022 to USD 443.1 million by 2029, registering a compound annual growth rate (CAGR) of
USD 1950 View ReportGlobal Digital Light Processing (DLP) Projector Market 2023
DescriptionThe Digital Light Processing (DLP) Projector Market is poised for significant growth, with a projected increase from USD 4.83 billion in 2022 to USD 7.19 billion by 2029. This growth
USD 1950 View ReportGlobal Digital Health and Wellness Market 2023
The global digital health market was valued at USD 328.3 billion in 2022 and is forecast to reach USD 1,037 billion by 2029, reflecting a compound annual growth rate of
USD 3450 View ReportFill The Form For Sample Request